NCT06604845

Brief Summary

Many adults with attention deficit hyperactivity disorder (ADHD) experience difficulties with inattention, planning and impulsivity that impacts work and social life negatively also after treatment with medication. There are various psychological treatments aiming to improve these symptoms, but it is not known if they work or not. The goal of this clinical trial is to evaluate group cognitive behavioural therapy (CBT) for adults with attention deficit hyperactivity disorder (ADHD) in comparison to an active control group consisting of a discussion and activity group. Previous research suggests that group CBT works about equally well as other structured group activities. The main questions the researchers aim to answer are if group CBT work better than activity groups to:

  • Improve symptoms of ADHD
  • Improve general mental health and life quality
  • Improve every-day functioning The researchers also want to learn if group CBT or activity groups work better for some people with ADHD depending on individual characteristics such as
  • type of symptoms, age, gender or co-occurring psychiatric diagnoses. The comparison is a manualised structured activity group given at the same number of sessions and same group size. All participants will visit our clinics at 12 occasions. They will:
  • Fill in questionnaires before and after the group intervention, and online after 6 and 12 months
  • Do cognitive testing before and after the intervention

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Sep 2024Jun 2026

Study Start

First participant enrolled

September 10, 2024

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 17, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 20, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

1.8 years

First QC Date

September 17, 2024

Last Update Submit

September 17, 2024

Conditions

Keywords

Attention Deficit Hyperactivity Disorder (ADHD)Cognitive Behavioral TherapyControlled Clinical Trials, RandomizedAdults

Outcome Measures

Primary Outcomes (2)

  • Change in Adult ADHD Self-Report Scale (ASRS)

    ASRS is a self-reported symptom questionnaire for adults with ADHD. It has 18 questions about how often the participant experiences a certain symptom, with five response choices ranging from 0 (never) to 4 (very often) points.

    From enrollment to the follow-up 12 months after end of treatment

  • Change in Clinical Global Impressions-Severity (CGI-S)

    CGI-S is a 7-point scale where the clinician rate the severity of the patients illness at the time of assessment.

    At enrollment and after 12 weeks at end of treatment

Secondary Outcomes (4)

  • Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM)

    From enrollment to the follow-up 12 months after end of treatment

  • Brunnsviken Brief Quality of Life Inventory (BBQ)

    From enrollment to the follow-up 12 months after end of treatment

  • Colour word Interference Test (CWIT)

    At enrollment and after 12 weeks at end of treatment

  • Trail Making Test (TMT)

    At enrollment and after 12 weeks at end of treatment

Other Outcomes (1)

  • Treatment Credibility questionnaire (TCS)

    At enrollment and after 12 weeks at end of treatment

Study Arms (2)

Group cognitive behavioural therapy

EXPERIMENTAL

Group CBT based on an adapted version of individual CBT for ADHD according to Safren's manual "CBT for ADHD/Mastering Your Adult ADHD".

Behavioral: Group cognitive behavioural therapy (CBT)

Activity group

ACTIVE COMPARATOR

The Activity group is a structured manualised group intervention designed by clinicians and researchers at Sahlgrenska University Hosptial.

Other: Activity group

Interventions

CBT based on Safren's manual "CBT for ADHD/Mastering Your Adult ADHD"20 adapted for group format. The program includes psychoeducation and cognitive restructuring and aims to improve ADHD symptoms, especially planning, organisation, attention and adaptive thinking. The CBT groups will meet at the clinic weekly for 12 weeks for 2 hours including a break in the middle. The groups are led by two clinicians.

Group cognitive behavioural therapy

The Activity group is a structured manualised group intervention designed for this and planned future studies of psychosocial treatments for adults with ADHD and/or autism. The program includes group discussions, peer-sharing and social every-day life activities. The Activity groups will meet at the clinic weekly for 12 weeks for 2 hours including a break in the middle. The groups are led by two trainers.

Activity group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahgrenska University Hospital

Gothenburg, Sweden

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2024

First Posted

September 20, 2024

Study Start

September 10, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

September 20, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Most individual data will be part of patients medical records.

Locations